Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Lupin Ltd.
NSE: LUPIN
|
BSE: 500257
|
ISIN: INE326A01037
|
Industry: Pharmaceuticals
Expansion
|
Mid-range Performer
2322.5000
71.00
(
3.15
%)
NSE
Mar 20, 2026
15:46 PM
Near 52W High of ₹2377.60
Volume:
1.1M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Lupin Ltd.
13 Feb 2025
Expansion
2322.50
3.15%
Result Update:Lupin
Buy:
Lupin Ltd.
by
Axis Direct
Target: 2500
Target
Axis Direct
We maintain our BUY rating on the stock.
Lupin Ltd. is trading above all available SMAs
More from Lupin Ltd.
Recommended
Market trades higher, Electrosteel Castings' promoter group acquires Rs 144 crore share
Trendlyne Marketwatch |
20 Mar 2026, 03:26PM
Superstar investors pay the price for crowded bets
The Baseline |
19 Mar 2026, 05:45PM
Lupin expects normalization by September quarter
|
17 Apr 2020